What do systematic reviews say?

Serious adverse events (proportion) · alcohol‐related disorders (others)

Serious adverse events (proportion) · alcohol‐related disorders (others)

Serious adverse events (proportion) · alcohol‐related disorders (others)

Serious adverse events (proportion) · people with primary biliary cholangitis

Serious adverse events (proportion) · people with primary biliary cholangitis

Serious adverse events (proportion) · people with primary biliary cholangitis

Adverse events considered non‐serious · participants with unresectable hepatocellular carcinoma

Serious adverse events ‐ not reported · farmworkers

Serious adverse events ‐ not reported · farmworkers, soldiers, and people in endemic areas

Serious adverse events ‐ not measured · older people in all long‐term care settings

Serious adverse events ‐ not reported · individuals with moderate to severe disease

Serious adverse events ‐ not reported · outpatients withmild disease

Serious adverse events ‐ not reported · systemic lupus erythematosus

Serious adverse events ‐ not reported · systemic lupus erythematosus

Serious adverse events ‐ not reported · systemic lupus erythematosus

Serious adverse events ‐ not reported · hospitalised and unvaccinated individuals with a confirmed or suspected diagnosis of symptomatic COVID‐19

Adverse events considered non‐serious · children with portal hypertension and large oesophageal varices, without previous gastrointestinal bleeding or beta‐blocker treatment

Serious adverse events ‐ not reported · women with recurrent or FIGO stage IVB cervical cancer

Adverse events/serious adverse events · people with NMD

Adverse events/serious adverse events · people with NMD